Compare BWAY & SNDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BWAY | SNDL |
|---|---|---|
| Founded | 2003 | 2006 |
| Country | Israel | Canada |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Pharmaceuticals and Biotechnology |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 450.8M | 386.3M |
| IPO Year | N/A | 2019 |
| Metric | BWAY | SNDL |
|---|---|---|
| Price | $13.76 | $1.51 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $13.25 | $5.00 |
| AVG Volume (30 Days) | 118.8K | ★ 961.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $301.23 | $6.09 |
| Revenue Next Year | $24.33 | $2.59 |
| P/E Ratio | $81.98 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.84 | $1.15 |
| 52 Week High | $26.63 | $2.89 |
| Indicator | BWAY | SNDL |
|---|---|---|
| Relative Strength Index (RSI) | 29.80 | 44.57 |
| Support Level | $11.55 | $1.44 |
| Resistance Level | $17.20 | $1.60 |
| Average True Range (ATR) | 1.07 | 0.07 |
| MACD | -0.81 | 0.00 |
| Stochastic Oscillator | 15.32 | 21.05 |
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.